Cargando…
Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes
BACKGROUND: Ivermectin (22,23-dihydroavermectin B(1a): H(2)B(1a)) is an endectocide used to treat worm infections and ectoparasites including lice and scabies mites. Furthermore, survival of malaria transmitting Anopheles mosquitoes is strongly decreased after feeding on humans recently treated with...
Autores principales: | Kern, Charlotte, Müller, Pie, Chaccour, Carlos, Liechti, Matthias E., Hammann, Felix, Duthaler, Urs |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290335/ https://www.ncbi.nlm.nih.gov/pubmed/37355605 http://dx.doi.org/10.1186/s12936-023-04624-0 |
Ejemplares similares
-
The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes
por: Duthaler, Urs, et al.
Publicado: (2021) -
Differential susceptibilities of Anopheles albimanus and Anopheles stephensi mosquitoes to ivermectin
por: Dreyer, Staci M., et al.
Publicado: (2018) -
Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study
por: Nicolas, Patricia, et al.
Publicado: (2021) -
Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
por: Chaccour, Carlos, et al.
Publicado: (2017) -
Laser induced mortality of Anopheles stephensi mosquitoes
por: Keller, Matthew D., et al.
Publicado: (2016)